Telehealth came out of the pandemic with real momentum. Regulatory flexibilities unlocked new prescribing models, reimbursement parity gave companies a commercial foundation to build on,…
Telehealth came out of the pandemic with real momentum. Regulatory flexibilities unlocked new prescribing models, reimbursement parity gave companies a commercial foundation to build on,…
The BioTech hiring market took a hard hit in 2023 and through much of 2024. Rising interest rates, a difficult IPO window, and a significant…
The Head of AI title is everywhere right now. Boards are asking whether they need one. Founders are debating what the role should own. And…
Real World Evidence has moved from the periphery of HealthTech to the centre of it. Regulators are accepting RWE in support of label expansions and…
The commercial success of GLP-1 receptor agonists has done something unusual for a pharmaceutical category: it has generated an entirely new HealthTech sector almost overnight. …
The Chief Product Officer role in HealthTech has always been more complex than its equivalent in consumer software. Clinical validation, regulatory pathway, patient safety obligations…
Genomics has moved from a specialist research discipline to a core pillar of modern healthcare, biotech, and life sciences innovation. In 2026, the U.S. genomics…
Remote healthcare (Or Telehealth) has become an increasingly popular option for both consumers and healthcare providers over the past few years (Driven by growth from…
Equity, Diversity, and Inclusion (EDI) is still an issue at the top of the agenda for many HealthTech companies, as data has shown that diverse…
The healthcare landscape continues to evolve quickly, and 2026 is shaping up to be a pivotal year for HealthTech innovation. As the industry faces growing…